Literature DB >> 33238047

Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.

A Osada1, I Matsumoto1, N Mikami1, A Ohyama1, I Kurata1, Y Kondo1, H Tsuboi1, A Ishigami2, Y Sano3, T Arai4, N Ise4, T Sumida1.   

Abstract

The citrullinated inter-alpha-trypsin inhibitor heavy chain 4 (cit-ITIH4) was identified as its blood level was associated with the arthritis score in peptide glucose-6-phosphate-isomerase-induced arthritis (pGIA) mice and the disease activity in patients with rheumatoid arthritis (RA). This study aimed to clarify its citrullination pathway and function as related to neutrophils. In pGIA-afflicted joints, ITIH4 and cit-ITIH4 levels were examined by immunohistochemistry (IHC), immunoprecipitation (IP) and Western blotting (WB), while peptidylarginine deiminase (PAD) expression was measured by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), IHC and immunofluorescent methods. The pGIA mice received anti-lymphocyte antigen 6 complex locus G6D (Ly6G) antibodies to deplete neutrophils and the expression of cit-ITIH4 was investigated by WB. The amounts of ITIH4 and cit-ITIH4 in synovial fluid (SF) from RA and osteoarthritis (OA) patients were examined by I.P. and W.B. Recombinant ITIH4 and cit-ITIH4 were incubated with sera from healthy volunteers before its chemotactic ability and C5a level were evaluated using Boyden's chamber assay and enzyme-linked immunosorbent assay (ELISA). During peak arthritic phase, ITIH4 and cit-ITIH4 were increased in joints while PAD4 was over-expressed, especially in the infiltrating neutrophils of pGIA mice. Levels of cit-ITIH4 in plasma and joints significantly decreased upon neutrophil depletion. ITIH4 was specifically citrullinated in SF from RA patients compared with OA patients. Native ITIH4 inhibited neutrophilic migration and decreased C5a levels, while cit-ITIH4 increased its migration and C5a levels significantly. Cit-ITIH4 is generated mainly in inflamed joints by neutrophils via PAD4. Citrullination of ITIH4 may change its function to up-regulate neutrophilic migration by activating the complement cascade, exacerbating arthritis.
© 2020 British Society for Immunology.

Entities:  

Keywords:  citrullinated proteins; inter-alpha-trypsin inhibitor heavy chain 4; peptidylarginine deiminase 4; rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 33238047      PMCID: PMC7874842          DOI: 10.1111/cei.13556

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  42 in total

1.  Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

Authors:  Violeta Romero; Justyna Fert-Bober; Peter A Nigrovic; Erika Darrah; Uzma J Haque; David M Lee; Jennifer van Eyk; Antony Rosen; Felipe Andrade
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

2.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Xiaotian Chang; Shinya Tokuhiro; Tetsuji Sawada; Masakatsu Suzuki; Miyuki Nagasaki; Makiko Nakayama-Hamada; Reimi Kawaida; Mitsuru Ono; Masahiko Ohtsuki; Hidehiko Furukawa; Shinichi Yoshino; Masao Yukioka; Shigeto Tohma; Tsukasa Matsubara; Shigeyuki Wakitani; Ryota Teshima; Yuichi Nishioka; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

3.  NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.

Authors:  Ritika Khandpur; Carmelo Carmona-Rivera; Anuradha Vivekanandan-Giri; Alison Gizinski; Srilakshmi Yalavarthi; Jason S Knight; Sean Friday; Sam Li; Rajiv M Patel; Venkataraman Subramanian; Paul Thompson; Pojen Chen; David A Fox; Subramaniam Pennathur; Mariana J Kaplan
Journal:  Sci Transl Med       Date:  2013-03-27       Impact factor: 17.956

4.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

Authors:  Floris A van Gaalen; Jill van Aken; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; Eric Zanelli; Walther J van Venrooij; Cornelis L Verweij; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2004-07

Review 5.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.

Authors:  Erik R Vossenaar; Albert J W Zendman; Walther J van Venrooij; Ger J M Pruijn
Journal:  Bioessays       Date:  2003-11       Impact factor: 4.345

Review 6.  Rheumatoid arthritis. The role of neutrophil activation.

Authors:  G Weissmann; H Korchak
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

7.  PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps.

Authors:  Pingxin Li; Ming Li; Michael R Lindberg; Mary J Kennett; Na Xiong; Yanming Wang
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

8.  Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.

Authors:  Judith Auer; Markus Bläss; Hendrik Schulze-Koops; Stefan Russwurm; Thomas Nagel; Joachim R Kalden; Martin Röllinghoff; Horst Ulrich Beuscher
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.

Authors:  Keiichi Iwanami; Isao Matsumoto; Yoko Tanaka; Asuka Inoue; Daisuke Goto; Satoshi Ito; Akito Tsutsumi; Takayuki Sumida
Journal:  Arthritis Res Ther       Date:  2008-11-07       Impact factor: 5.156

10.  Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils.

Authors:  Yebin Zhou; Bo Chen; Nanette Mittereder; Raghothama Chaerkady; Martin Strain; Ling-Ling An; Saifur Rahman; Wenting Ma; Choon Pei Low; Denice Chan; Frances Neal; Clifton O Bingham; Kevon Sampson; Erika Darrah; Richard M Siegel; Sarfaraz Hasni; Felipe Andrade; Katherine A Vousden; Tomas Mustelin; Gary P Sims
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 8.786

View more
  1 in total

1.  Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.

Authors:  Kejian He; Sanshan He; Min Su
Journal:  J Clin Lab Anal       Date:  2022-01-22       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.